Metabolic alkalosis classification: Difference between revisions

	Metabolic alkalosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Metabolic alkalosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Metabolic alkalosis classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Metabolic alkalosis classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Metabolic alkalosis classification
CDC on Metabolic alkalosis classification
Metabolic alkalosis classification in the news
Blogs on Metabolic alkalosis classification
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Metabolic alkalosis classification

VisualWikitext

Revision as of 05:03, 20 January 2021

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S [2]

Overview

Metabolic Alkalosis can be classified according to pathophysiology, etiology and chloride responsiveness.

Classification

The following classification of Metabolic Alkalosis is based on Pathophysiology:

{{Family tree | | | | A01 | | | |A01= Metabolic Alkalosis}

Stimulation on Collecting Duct

Primary stimulation by Mineralocorticoid Excess causing HTN: •Congenital Adrenal Hyperplasia
•Cushing Syndrome
•Primary aldosteronism
•Renin Secreting tumors
•Medications(Fluoroprednisolone, Fludrocortisone)
•Liddle Syndrome
•11 beta hydroxysteroid dehydrogenase deficiency

Secondary Stimulation by Chloride depletion causing normal or low blood pressure: •Vomiting
•NG tube intubation
•Congenital Chloridorrhea
•Ileostomy
•Cystic fibrosis
•Diuretics
•Bartter syndrome
•Gitelman syndrome
•Hypokalemia

References

Template:WH Template:WS

@@ Line 2: / Line 2: @@
 {{Metabolic alkalosis}}
-{{CMG}}; {{AE}}
+{{CMG}}; {{AE}} {{MMT}}
 ==Overview==
-There is no established system for the classification of [disease name].
+Metabolic Alkalosis can be classified according to pathophysiology, etiology and chloride responsiveness.
-OR
-[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
-OR
-[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
-[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
-OR
-Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
-OR
-If the staging system involves specific and characteristic findings and features:
-According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
-OR
-The staging of [malignancy name] is based on the [staging system].
-OR
-There is no established system for the staging of [malignancy name].
 ==Classification==
+The following classification of Metabolic Alkalosis is based on Pathophysiology:
-*There is no established system for the classification of [disease name].
+{{Family tree/start}}
-OR
+{{Family tree | | | | A01 | | | |A01= Metabolic Alkalosis}
-*[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
+{{Family tree | | | | |!| | | | | }}
-**[Group1]
+{{Family tree | | | | B01 | | | |B01= Stimulation on Collecting Duct}}
-**[Group2]
+{{Family tree | |,|-|-|^|-|-|.| | }}
-**[Group3]
+{{Family tree | C01 | | | | C02 |C01= Primary stimulation by Mineralocorticoid Excess causing HTN: •Congenital Adrenal Hyperplasia <br>•Cushing Syndrome <br>•Primary aldosteronism <br>•Renin Secreting tumors <br>•Medications(Fluoroprednisolone, Fludrocortisone) <br>•Liddle Syndrome <br>•11 beta hydroxysteroid dehydrogenase deficiency | C02= Secondary Stimulation by Chloride depletion causing normal or low blood pressure: •Vomiting <br>•NG tube intubation <br>•Congenital Chloridorrhea <br>•Ileostomy <br>•Cystic fibrosis <br>•Diuretics <br>•Bartter syndrome <br>•Gitelman syndrome <br>•Hypokalemia}}
-**[Group4]
+{{Family tree/end}}
-OR
-*[Disease name] may be classified into [large number > 6] subtypes based on:
-**[Classification method 1]
-**[Classification method 2]
-**[Classification method 3]
-*[Disease name] may be classified into several subtypes based on:
-**[Classification method 1]
-**[Classification method 2]
-**[Classification method 3]
-OR
-*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
-OR
-*If the staging system involves specific and characteristic findings and features:
-*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
-OR
-*The staging of [malignancy name] is based on the [staging system].
-OR
-*There is no established system for the staging of [malignancy name].
 ==References==

Metabolic alkalosis classification: Difference between revisions

Revision as of 05:03, 20 January 2021

Overview

Classification

References

Navigation menu